Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects
Phase of Trial: Phase IV
Latest Information Update: 16 May 2008
At a glance
- Drugs Atorvastatin (Primary)
- Indications Lipid metabolism disorders
- Focus Pharmacodynamics
- 16 May 2008 Status changed from in progress to completed.
- 04 Nov 2006 New trial record.